Non-Arteritic Anterior Ischaemic Optic Neuropathy Associated with Semaglutide use.

Ir Med JSep 28, 2026 (epub)

M Kearney, N M Smyth, H S A Hassan et al.

✦ AI-curated · Sources linked

Case in brief

A woman in her 70s with vascular risk factors presented with a three-day history of progressive left-sided visual disturbance. Examination revealed a left relative afferent pupillary defect and inferior quadrantopia. Neuroimaging and haematological investigations were unremarkable. Formal assessment indicated superior optic disc swelling consistent with non-arteritic ischaemic optic neuropathy (NAION). Following the discontinuation of semaglutide, which she had been taking for six months, her visual acuity partially improved.

What made this case unusual

The potential association between semaglutide use and the development of NAION is noteworthy, as this connection has not been widely reported.

Diagnostic / clinical pearl

Clinicians should consider the possibility of drug-related adverse effects, such as NAION, in patients presenting with acute visual disturbances, especially those on semaglutide.

Why it matters

This case emphasizes the need for ongoing pharmacovigilance in the context of new medications and their potential ocular side effects.

Source

Published in Ir Med J. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Ophthalmology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.